PerkinElmer Life Sciences Announces Availability of SpectraPlate Microplates
17-Oct-2002
BOSTON, Oct 16, 2002 - PerkinElmer Life Sciences, a leading
provider of drug discovery, life science research and genetic disease
screening solutions, today announced the commercial availability of a
full range of clear SpectraPlate microplates. The new range consists
of 96- and 384-well clear microplates in three different formats:
1) SpectraPlates with medium protein binding affinity (MB)
2) high protein binding affinity (HB)
3) tissue culture treated plates (TC) for adherent cell culturing
The SpectraPlates are designed for use with Enzyme Linked
Immuno-Sorbent Assays (ELISA) and other colorimetric assays.
Key features of the SpectraPlate microplates include:
* An innovative pinch bar design facilitates automated robotic
handling.
* Manufactured under strict clean room conditions to avoid dust and
other contaminants.
* Very low intra-plate CV's and background readings ensure high
quality results.
* Increased nesting space and added bottom ribs that are guaranteed
compatible with PerkinElmer-supplied instrumentation.
* Unique design helps reduce instrument down time due to plate jams.
"These clear SpectraPlates complement PerkinElmer's wide range of
existing application-focused microplates," said Paul Gillyon, vice
president and general manager, Biomics and Research Products,
PerkinElmer Life Sciences. "This is one more example of how listening
to our customers' needs contributes to our ability to offer the latest
and most complete solutions in the industry."
Most read news
Other news from the department research and development

Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.